Vivos Inc (RDGL)

[SC8]

For background, RDGL is fairly priced in the 5 cent range given the risk. Dec. offering for more than 4% of company was in the 6 cent range. Retail person buying flea farts atm should reasonably expect to pay less, hence the 5 cent range. Moreover, to close last offering, MK had to renegotiate expiring warrants from previous offerings out to 2027; that says it all. Then there's fact MK failed to get Radiogel to market before the last of original patents expired in 2022, so any mega buyout offer potential is now off the table. That said, RDGL remains a lesser FDA play and people can trade it accordingly if they so wish.

Back to the moment, RDGL is having trouble holding a nickle now because of MK's piss poor management and proven serial lying. Only thing that matters now is getting Radiogel to human trials, and MK has made clear in last few updates, that is his lowest priority. Sadly, IsoPet remains his highest priority and the market doesn't care about IsoPet, as it was launched 5 years ago and never took off.

Those are the facts.